These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33911135)

  • 1. Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients.
    Nived P; Pettersson Å; Jönsson G; Bengtsson AA; Settergren B; Skattum L; Johansson Å; Kapetanovic MC
    Sci Rep; 2021 Apr; 11(1):9199. PubMed ID: 33911135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
    Kapetanovic MC; Nagel J; Nordström I; Saxne T; Geborek P; Rudin A
    Vaccine; 2017 Feb; 35(6):903-908. PubMed ID: 28081972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate Treatment Suppresses Monocytes in Nonresponders to Pneumococcal Conjugate Vaccine in Rheumatoid Arthritis Patients.
    Elmér E; Nived P; Pettersson Å; Skattum L; Hellmark T; Kapetanovic MC; Johansson ÅCM
    J Immunol Res; 2022; 2022():7561661. PubMed ID: 35935581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
    Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
    Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.
    Bingham CO; Looney RJ; Deodhar A; Halsey N; Greenwald M; Codding C; Trzaskoma B; Martin F; Agarwal S; Kelman A
    Arthritis Rheum; 2010 Jan; 62(1):64-74. PubMed ID: 20039397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs.
    Kapetanovic MC; Roseman C; Jönsson G; Truedsson L
    Clin Rheumatol; 2011 Dec; 30(12):1555-61. PubMed ID: 21956234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis.
    Crnkic Kapetanovic M; Saxne T; Jönsson G; Truedsson L; Geborek P
    Arthritis Res Ther; 2013 Oct; 15(5):R171. PubMed ID: 24286269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of abatacept on the immunogenicity of 23-valent pneumococcal polysaccharide vaccination (PPSV23) in rheumatoid arthritis patients.
    Migita K; Akeda Y; Akazawa M; Tohma S; Hirano F; Ideguchi H; Kozuru H; Jiuchi Y; Matsumura R; Suematsu E; Miyamura T; Mori S; Fukui T; Izumi Y; Iwanaga N; Tsutani H; Saisyo K; Yamanaka T; Ohshima S; Mori N; Matsumori A; Takahi K; Yoshizawa S; Kawabe Y; Suenaga Y; Ozawa T; Hamada N; Komiya Y; Matsui T; Furukawa H; Oishi K
    Arthritis Res Ther; 2015 Dec; 17():357. PubMed ID: 26653668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept.
    Rákóczi É; Perge B; Végh E; Csomor P; Pusztai A; Szamosi S; Bodnár N; Szántó S; Szücs G; Szekanecz Z
    Joint Bone Spine; 2016 Dec; 83(6):675-679. PubMed ID: 26995488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate.
    Migita K; Akeda Y; Akazawa M; Tohma S; Hirano F; Ideguchi H; Matsumura R; Suematsu E; Miyamura T; Mori S; Fukui T; Izumi Y; Iwanaga N; Jiuchi Y; Kozuru H; Tsutani H; Saisyo K; Yamanaka T; Ohshima S; Mori N; Matsumori A; Kitagawa K; Takahi K; Ozawa T; Hamada N; Nakajima K; Nagai H; Tamura N; Suenaga Y; Kawabata M; Matsui T; Furukawa H; Kawakami K; Oishi K
    Medicine (Baltimore); 2015 Dec; 94(52):e2184. PubMed ID: 26717361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs.
    Crnkic Kapetanovic M; Saxne T; Truedsson L; Geborek P
    Arthritis Res Ther; 2013 Jan; 15(1):R1. PubMed ID: 23286772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
    Kapetanovic MC; Saxne T; Sjöholm A; Truedsson L; Jönsson G; Geborek P
    Rheumatology (Oxford); 2006 Jan; 45(1):106-11. PubMed ID: 16287919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy.
    Mori S; Ueki Y; Akeda Y; Hirakata N; Oribe M; Shiohira Y; Hidaka T; Oishi K
    Ann Rheum Dis; 2013 Aug; 72(8):1362-6. PubMed ID: 23345600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone.
    Visvanathan S; Keenan GF; Baker DG; Levinson AI; Wagner CL
    J Rheumatol; 2007 May; 34(5):952-7. PubMed ID: 17444589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudy.
    Winthrop KL; Bingham CO; Komocsar WJ; Bradley J; Issa M; Klar R; Kartman CE
    Arthritis Res Ther; 2019 Apr; 21(1):102. PubMed ID: 30999933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus.
    Migita K; Akeda Y; Akazawa M; Tohma S; Hirano F; Ideguchi H; Matsumura R; Suematsu E; Miyamura T; Mori S; Fukui T; Izumi Y; Iwanaga N; Tsutani H; Saisyo K; Yamanaka T; Ohshima S; Sugiyama T; Kawabe Y; Katayama M; Suenaga Y; Okamoto A; Ohshima H; Okada Y; Ichikawa K; Yoshizawa S; Kawakami K; Matsui T; Furukawa H; Oishi K
    Arthritis Res Ther; 2015 Jun; 17(1):149. PubMed ID: 26036592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients.
    Nived P; Jönsson G; Settergren B; Einarsson J; Olofsson T; Jørgensen CS; Skattum L; Kapetanovic MC
    Arthritis Res Ther; 2020 Feb; 22(1):36. PubMed ID: 32087733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Janus kinase inhibitors on antibody response to 13-valent pneumococcal conjugate vaccine in patients with rheumatoid arthritis.
    Mori S; Ueki Y; Ishiwada N
    Mod Rheumatol; 2023 Mar; 33(2):312-317. PubMed ID: 35348759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate.
    Coulson E; Saravanan V; Hamilton J; So KL; Morgan L; Heycock C; Rynne M; Kelly C
    Ann Rheum Dis; 2011 Jul; 70(7):1289-91. PubMed ID: 21515601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Homing Potentials of Streptococcus pneumoniae-Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations.
    Palkola NV; Pakkanen SH; Kantele JM; Pakarinen L; Puohiniemi R; Kantele A
    J Infect Dis; 2015 Oct; 212(8):1279-87. PubMed ID: 25838267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.